Amova Adds to Frencken & UI Boustead REIT Positions

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Over the five sessions, close to 70 director interests and substantial shareholdings were filed for more than 35 primary-listed stocks.

Directors or CEOs reported six acquisitions and no disposals, while substantial shareholders recorded six acquisitions and four disposals. This included CEO or director acquisitions filed for AcroMeta, All-Link Air & Sea, PNE Industries, Stamford Land and SunMoon Food.


Share Buybacks 

In addition, the five sessions saw seven primary-listed companies conduct buybacks with a total consideration of S$26.2 million, a similar pace to the previous week. 

Singtel has led both the July and 2026 year-to-date buyback consideration tallies, repurchasing 23.6 million shares for S$103.6 million at an average price of S$4.40 per share in July, bringing its repurchases over the seven months to 195.3 million shares for S$893.0 million at an average price of S$4.57 per share. Singtel has stated that shares repurchased under its S$2 billion Value Realisation Share Buyback programme are cancelled, reducing the total number of shares outstanding and increasing each remaining shareholder's ownership interest in the company. The group added that full execution of its S$2 billion Value Realisation Share Buyback programme would, on a pro-forma FY26 basis, deliver a permanent approximately 3 per cent uplift in underlying EPS and support a higher EPS and Dividend Per Share trajectory.

Secondary-listed companies were also active on buybacks over the past seven months. Jardine Matheson Holdings repurchased more than 3.7 million shares for around US$270 million at an average price of US$71.41 per share. This aligns with management’s broader capital allocation framework, where buybacks form part of value creation alongside accelerated capital recycling and a strengthened net cash position. Hongkong Land also repurchased more than 27 million shares for around US$210 million at an average price of US$7.63 per share. 


All-Link Air & Sea: Mdm Tang Ying Increases Stake on Debut Day

Executive Director and substantial shareholder Mdm Tang Ying acquired 5,050,800 shares on 5 August, the first day of trading for All-Link Air & Sea on the SGX Mainboard. The acquisition increased her direct interest from 51.7 per cent to 55.02 per cent. The group raised gross proceeds of approximately S$20.1 million from its IPO. 

Its post-IPO priorities are centred on diversifying its customer base and expanding across ASEAN. Vietnam and Thailand have been identified as key growth markets, supported by a call option over a 30.0 per cent interest in All-Link Vietnam. Customer concentration has also moderated, with the TikTok Group contributing approximately 45.4 per cent of FY25 revenue compared with approximately 98.0 per cent in FY24, while a new US-listed technology customer contributed approximately 33.6 per cent of FY25 revenue.


MediNex CEO Jessie Low Adds to Stake

On 5 August, MediNex Executive Director and Chief Executive Officer Jessie Low Mui Choo acquired 400,000 shares for S$92,000, or S$0.23 per share. The married deal increased her direct interest from 28.54 million shares to 28.94 million shares, while her total interest, including the 390,000 shares deemed held through her spouse, rose to 29.33 million shares, equivalent to 21.8 per cent of the company’s issued share capital.

Ms Low has led MediNex’s acquisition-led development since its Catalist listing in 2018. The company’s IPO proceeds were partly earmarked to expand through acquisitions, joint ventures and strategic partnerships, with S$3.53 million of the S$4.0 million allocated for this purpose utilised as at the FY26 annual report. This included the acquisition of Sen Med Holdings, Ark Leadership & Learning, SKI Consultancy and MDX Advisory, supporting MediNex’s build-out from a medical support services provider into a broader platform spanning medical support, business support, pharmaceutical services and advisory capabilities.

For FY26 (ended 31 March), MediNex reported revenue of S$12.4 million, down 3.1 per cent year-on-year, mainly due to lower pharmaceutical services revenue after the loss of a major customer, partly offset by growth in medical support services from new clinic setup projects. Profit attributable to shareholders declined 21.5 per cent to S$2.2 million after a non-cash goodwill impairment of approximately S$1.6 million relating to Nex Healthcare. Excluding the impairment, profit before goodwill impairment improved to S$3.8 million, while operating cash flow remained positive at S$2.7 million. 


PNE Industries Managing Director Tan Koon Chwee Adds to Stake

On 3 August, PNE Industries Managing Director Tan Koon Chwee acquired 132,400 shares for S$51,636, or S$0.39 per share, via a market transaction. The purchase increased his direct interest from 9.48 million shares to 9.62 million shares, equivalent to 11.46 per cent of the company’s issued share capital.

The acquisition comes after PNE reported its 1HFY26 (ended 31 March) revenue declined 10.5 per cent year-on-year to S$31.3 million and the group recorded a loss before tax of S$0.7 million, compared with profit before tax of S$0.7 million in 1HFY25. The decline was mainly due to lower customer demand in the contract manufacturing segment, partly offset by higher orders from the trading segment. Gross profit margin also narrowed to 14.0 per cent from 14.9 per cent, reflecting lower revenue and reduced economies of scale.

The balance sheet remained supported by cash generation and a debt-free position. Net cash generated from operating activities rose to S$7.0 million for 1HFY26, while cash and bank balances increased to S$22.9 million as of 31 March. Inventories fell by S$6.4 million and trade receivables declined by S$2.7 million, in line with lower sales and the fulfilment of customer orders using existing stock. The group had no bank borrowings, with lease liabilities attributable to right-of-use assets.

Management said it continues to focus on cost control, operational efficiencies and customer-base diversification, while foreign exchange volatility remains a key risk given the group’s US dollar sales exposure and Malaysian ringgit cost base.


Amova Asia Increases Frencken Stake Above 7 Per Cent

On 6 August, Amova Asset Management Asia reported that its deemed interest in Frencken Group had increased from 29.74 million shares, or 6.93 per cent, to 30.66 million shares, or 7.14 per cent, following the acquisition of 924,600 shares on 3 August at an average price of approximately S$2.51 per share. At the group level, Amova Asset Management Co., Ltd increased its deemed interest from 29.92 million shares, or 6.97 per cent, to 30.85 million shares, or 7.19 per cent. Amova Asia first became a substantial shareholder on 30 March when its interest increased to 5.08 per cent, and subsequently increased its stake above the 6 per cent threshold on 2 June.

Frencken Group provides technology solutions to the semiconductor, analytical and life sciences, medical, automotive and industrial automation industries through its Mechatronics and IMS divisions. The group has advised that it will release its financial results for the six months ended 30 June on 13 August. 


UI Boustead REIT: Amova Crosses 7 Per Cent Threshold as Growth Pipeline Advances

On 28 July, Amova Asset Management acquired 2.76 million units in UI Boustead REIT for S$2.23 million, or approximately S$0.81 per unit, increasing its deemed interest from 93.16 million units (6.82 per cent) to 95.92 million units (7.02 per cent). The purchase lifted the fund manager above the 7 per cent substantial unitholder threshold. 

Amova had first emerged as a substantial unitholder in March with a 5.1 per cent interest and subsequently increased its deemed interest to 6.38 per cent in May. 

The stake increase comes as UI Boustead REIT continues to execute multiple growth initiatives. As of 30 June, the REIT's portfolio comprised 23 properties across Singapore and Japan with 98.1 per cent committed occupancy and a portfolio weighted average lease expiry of 5.4 years. Management also highlighted S$74.7 million of co-investments across development projects and a S$2.6 million asset enhancement initiative at 84 Boon Keng Road. 

The REIT is pursuing inorganic growth through development partnerships alongside its sponsor, including a 24.26 per cent interest in the UIB Konan Phase 3 logistics development in Japan and a 51 per cent interest in a build-to-suit aerospace facility in Seletar Aerospace Park. The aerospace project has an estimated development cost of S$104 million, an expected yield on cost of 8.6 per cent and a tenant lease of approximately 22.5 years with built-in rental escalations. Meanwhile, the asset enhancement initiative at 84 Boon Keng Road is expected to complete by end-2026, with about 40 per cent of the space already pre-leased. 

On 29 July, Maybank Research maintained its buy recommendation on UI Boustead REIT with a target price of S$1.03. The broker highlighted the REIT's improving occupancy trend, positive 2.6 per cent rental reversions in Singapore and development projects that remain on track. Maybank noted that income contributions from the 84 Boon Keng Road asset enhancement initiative and improved occupancy could help offset the impact of Japanese yen weakness. UOB Kay Hian maintained its buy recommendation on UI Boustead REIT with a target price of S$1.16, citing improving operating momentum, positive Singapore rental reversions and full occupancy across the Japan portfolio.


Aedge Completes Fully Subscribed S$3.5 Million Placement to Support Investment Properties Growth

Aedge completed its proposed placement of 16.7 million new shares at S$0.21 per share on 6 August, increasing its issued share base from 161.9 million shares to 178.6 million shares. The placement shares are expected to list on Catalist on or around 7 August and rank pari passu with existing shares, except for distributions with record dates on or before completion. The placement was fully subscribed and anchored by institutional and strategic investors including Azure Capital and ICH Synergrowth Fund, with Aedge stating that the net proceeds of approximately S$3.4 million will support the growth of its investment properties division and general working capital.

Share Buybacks by Primary-listed Companies by way of Market Acquisition (31 July to 6 August)Number of Shares/Units Purchased Buyback Consideration (incl stamp duties & clearing charges) S$   Avg price paid per share S$
KEPPEL 1,700,00019,225,98011.31
RAFFLES MEDICAL GROUP 2,860,0002,532,2840.89
THE HOUR GLASS 780,9002,151,4422.76
SEATRIUM 900,0001,996,4852.22
RECLAIMS GLOBAL 1,282,300273,0000.21
SINGAPORE SHIPPING CORPORATION 100,60030,2100.30
JASON MARINE GROUP 1,6002920.18
Total7,625,40026,209,694 


Inside Insights is a weekly column on The Business Times, read the original version.

Enjoying this read?

  • Subscribe now to our SGX My Gateway newsletter for a compilation of latest market news, sector performances, new product release updates, and research reports on SGX-listed companies.

Source: SGX The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.